Tech Transfer

Microgrids meet the market

Nathan Kahl — Fri, 02 Oct 2026 12:47:36 +0000

Microgrids meet the market Nathan Kahl Fri, 10/02/2026 - 08:47

For a large organization, cutting the electric bill isn't necessarily as simple as using less electricity. In fact, avoiding one brief spike in demand can save far more money than reducing overall consumption.

Alex Brodsky, a professor in the Department of Computer Science. Photo provided

Alex Brodsky, a professor in the 911�� Department of Computer Science, and his research team developed technology that can help organizations make complex decisions about how to manage energy resources and evaluate potential investments.

A $50,000 National Science Foundation (NSF) grant through its Innovation Corps (I-Corps) program is helping Brodsky explore how to move that technology from research to market. I-Corps teaches researchers to evaluate the commercial potential of technologies developed through academic research. Participants identify possible markets and customers and conduct at least 100 interviews with those potential customers.

“The interviews are instrumental,” Brodsky said. “Some of your hypotheses turn out to be false, while other things you hadn't considered turn out to be true.”

Much of this I-Corps work is being led by Xu (Ethan) Han, a former PhD student of Brodsky's who is now a faculty member in 911��'s Department of Computer Science. Han serves as an entrepreneurial lead for the project, called Microgrid Optima.

Microgrids coordinate multiple energy resources within a local energy system. They can integrate electricity from the power grid with on-site generation, energy storage, building systems, and other energy resources.

Microgrid Optima helps determine how those resources should work together. Instead of relying primarily on preset operating schedules, the system can recommend what individual components should do at intervals throughout the day. It can also help organizations decide which new energy resources make financial sense before making potentially expensive investments. Many commercial and industrial customers’ electric bills are determined not by just how much electricity they use, but also by what their peak demand is; a short period of unusually high demand can significantly affect future bills.

An organization might thus choose to use a battery during a demand spike and recharge it later. “Energy storage by itself doesn't save the total amount of energy you use,” Brodsky said, but this strategy may reduce peak usage enough to produce substantial savings. As a result, investing in an expensive battery can sometimes quickly pay for itself.

The challenge is figuring out when such an investment makes sense and how it interacts with everything else in the system. “Thinking of how you invest in each component in isolation is a bad approach, because the components have a very strong operational interaction,” he said.

The team is exploring a range of potential markets for the technology, with the I-Corps interviews helping identify which types of organizations and energy environments present the strongest opportunities. One seemingly obvious market, data centers, is less promising because their operators place a much higher priority on securing enough electrical capacity than on reducing costs.

Microgrid Optima draws on decision-guidance technology Brodsky's research group developed over many years and applied to problems ranging from energy and autonomous vehicles to pandemic response. During the COVID pandemic, Brodsky worked with 911�� epidemiologist Amira Roess in the College of Public Health to develop a system for evaluating combinations of testing, contact tracing, symptom reporting, and other mitigation measures. The university adopted many of the team's recommendations.

The I-Corps program could be an early step toward bringing the latest application of that technology to customers. After the team's interviews help identify its most promising market, Brodsky said, other federal programs, including Small Business Innovation Research and Small Business Technology Transfer funding, could provide routes toward commercialization.

Explore Research at 911��

In This Story

Alex Brodsky

Topics

computer science

I-Corps

National Science Foundation

Energy

Tech Transfer

Research

College of Engineering and Computing

911�� licenses cancer imaging technology to biotech company

ckearney — Fri, 31 Jul 2026 14:54:52 +0000

911�� licenses cancer imaging technology to biotech company ckearney Fri, 07/31/2026 - 10:54

SonoVanta™, a patent-pending contrast agent that improves the precision of cancer margin imaging, is the second technology from 911�� to be licensed through the Virginia Innovation Partnership Corporation’s (VIPC) Lab-to-Launch (L2L) Program, which accelerates the commercialization of promising research breakthroughs emerging from Virginia’s universities.

From left, John Hart, president and CEO of NanOptical; Amy Adams, executive director of Nexus234 Innovation District; Remi Veneziano, associate professor, bioengineering, 911��; and Helena Kondow-McConaghy, business development manager, PWCDEDT. Photo provided

SonoVanta™ originated from research conducted at 911�� bioengineering researchers Parag Chitnis and Remi Veneziano. NanOptical Biomedical Inc., a biotechnology company working on next-generation contrast agents for photoacoustic imaging, has licensed the technology. Photoacoustic imaging combines laser light and ultrasound to produce high-resolution views of tissue. The effectiveness of the technology depends in part on contrast agents that enhance the visibility of diseased tissue.

Successful commercialization of contrast agents depends on biocompatibility and scalable manufacturing. NanOptical Biomedical's platform addresses these challenges.

“SonoVanta™ was created to address one of the biggest barriers to the broader adoption of photoacoustic imaging,” said Chitnis. “By using an FDA-approved near-infrared dye, we devised a platform that enables disease-specific targeting and makes manufacturing and implementation easier.”

The company anticipates commercial availability this fall as an advanced tool for cell, tissue, and organ imaging, with applications across numerous areas of biomedical research and development. They hope to expand the technology's use in surgical oncology, with the goal of optimizing visualization of breast tumor margins during cancer procedures.

The L2L initiative, developed through a collaboration between VIPC and the state’s six R1 research university partners, aims to significantly increase the number of start-ups emerging from Virginia’s universities and help move technological breakthroughs to the marketplace, through a “fast track license.” Instead of taking months, a licensing agreement can now take weeks.

911�� bioengineering researchers Parag Chitnis and Remi Veneziano. Photo provided

NanOptical Biomedical's arrival represents an important milestone in bringing university-developed technology into research and clinical imaging.

“NanOptical Biomedical was formed to translate a strong university innovation into a commercially viable platform with meaningful market potential,” said John Hart, president and CEO of NanOptical Biomedical. “Our initial focus is to serve research customers in academia, biotech, and the pharmaceutical sector, while also pursuing the regulatory pathway for future clinical applications in surgical oncology. We believe SonoVanta™ offers a valuable solution to deliver more precise imaging and address a critical need in cancer care.”

"Eight years ago, Dr. Chitnis and I were standing in front of a whiteboard tossing ideas back and forth," said Veneziano. "We’re excited to watch this technology grow from an idea into a new biotechnology company."

NanOptical Biomedical began operations at the Endeavor life science incubator in the Nexus234 Innovation District in Prince William County, Virginia. Hart said the company chose Prince William County as its first operating location to stay close to 911�� and the region's thriving life sciences industry. The company is joining Nexus234, Northern Virginia's first innovation district, which Real FDI named one of the Top 10 Life Sciences Projects globally in March 2026.

“NanOptical Biomedical is exactly the kind of company Nexus234 was created to attract and empower,” said Christina Winn, executive director of the Prince William County Department of Economic Development and Tourism. "This achievement reflects the strength of the region's entrepreneurial ecosystem and the environment Prince William County has built for start-ups, research commercialization, and the life sciences industry."

NanOptical Biomedical's establishment in Nexus234 reinforces the region's commitment to cultivating an ecosystem that helps translate research and entrepreneurship into company success and job creation.

Earlier this year, 911�� was Virginia’s first R1 research institution to commercialize a product under the L2L initiative. In January, the 911�� Research Foundation entered into a license agreement with serial entrepreneur Anthony Fung and his company Valorlox LLC for the patented technology Dynamic Low Visibility Pneumatic Cofferdam, a coastal resilience system designed to protect against flooding.

Learn more about 911��'s Grand Challenge Initiative

Topics

College of Engineering and Computing

GCI-Health

911�� and Phase Inc. receive NSF grant to advance 3D-printed microfluidic technology

Martha Bushong — Wed, 01 Jul 2026 18:37:20 +0000

911�� and Phase Inc. receive NSF grant to advance 3D-printed microfluidic technology Martha Bushong Wed, 07/01/2026 - 14:37

911�� and Phase Inc. have received a National Science Foundation (NSF) STTR grant to advance a new generation of 3D-printed microfluidic devices that could help move the technologies from the research lab toward broader commercial and scientific use.

Ramin M. Hakami and Remi Veneziano. Photo provided

The project combines the expertise of College of Science Professor Ramin M. Hakami’s group in extracellular vesicle (EV) biology, and that of College of Engineering and Computing Associate Professor Remi Veneziano’s group in bioengineering and materials characterization, at 911�� with Phase’s vision to create an end-to-end, automated microfluidic platform that brings together custom device design, scalable 3D-printed polydimethylsiloxane (PDMS) chip manufacturing, and automated fluid handling. Specifically, this project leverages the microfluidic EV platform jointly developed and published by the Veneziano and Hakami groups.

Microfluidic devices use tiny channels to control small amounts of fluid and recreate environments on a cellular scale. They model human biology more realistically than flat cell cultures, making them important for drug discovery, disease research, and toxicology. Microfluidics are especially timely as the FDA has announced plans to phase out some animal testing requirements and encourage more human-relevant methods.

Today, producing complex PDMS microfluidic devices often requires cleanrooms, manual optimization, and repeated trial-and-error. The NSF-supported work is designed to reduce that bottleneck by using thermal and curing models to predict how PDMS will behave during printing, then optimize print parameters before a device is manufactured.

Photo provided

“This partnership helps us move one step closer to a fully automated, scalable microfluidic platform,” said Jeff Schultz, principal investigator and co-founder of Phase, which is headquartered in Charlotte, North Carolina. “Our goal is to make microfluidic technology more reproducible and more accessible to researchers and companies working to develop better human-relevant models.”

911�� researchers will help characterize the printed devices for dimensional accuracy, surface quality, batch-to-batch consistency, and biological function. The team will also test a device designed to study EV function. EVs are nanoparticles that are released by cells and play critical roles in intercellular communication. They have been shown to carry important regulatory functions in various human diseases, such as cancer, infectious disease, and neurological disorders, and are also highly advantageous for use in drug delivery.

“Being able to rapidly and cost‑effectively prototype and fabricate custom microfluidic devices will significantly enhance our capacity to design relevant microphysiological systems and will help broaden access to this technology to many research laboratories” said Veneziano.

“Our microfluidic device empowers researchers to conduct functional EV studies with ease and under physiologically relevant conditions. Through our partnership with Phase to 3D print the chips, we will be able to deliver more reliable, cost-effective, and commercially viable tools to the EV scientific community,” said Hakami, co-director of the Center for Infectious Disease Research at 911��.

For Phase, the NSF grant builds on a growing base of support from federal and private sources. The company has already received more than $3.5 million in nondilutive funding, including support from the National Institutes of Health, the One North Carolina Small Business Program, the North Carolina Biotechnology Center, NSF, and private-sector partners. Previous research partners include Harvard Medical School, Georgia Tech, and Virginia Tech.

By pairing 911��’s biological and engineering strengths with Phase’s manufacturing platform, the project is positioned to advance both scientific discovery and commercialization. The result could be a more reliable path for producing the microfluidic tools needed to support the next wave of biomedical research, organ-on-a-chip development, and human-centered bio-innovation.

This research supports the Grand Challenge Initiative's goal of improving human health, well-being, and preparedness

Discover more GCI health and well-being research >>

Learn about other solutions >>

Explore Research at 911��

In This Story

Remi Veneziano

Topics

College of Engineering and Computing

GCI-Health

National Science Foundation

Imagining an imaging breakthrough

Nathan Kahl — Mon, 27 Apr 2026 12:08:24 +0000

Imagining an imaging breakthrough Nathan Kahl Mon, 04/27/2026 - 08:08

In This Story

Remi Veneziano

Parag Chitnis

A research team at 911�� is working to move a promising medical imaging technology closer to real-world use, supported by a new grant from the Virginia Innovation Partnership Corporation (VIPC).

911�� researchers Parag Chitnis and Remi Veneziano. Photo provided

Associate Professor Remi Veneziano and Professor Parag Chitnis in the Department of Bioengineering received a Tier 2 VIPC award to advance the development of a contrast agent for photoacoustic imaging. The two-year, $200,000 grant will support efforts to scale-up production and demonstrate that the material can be manufactured consistently for translation outside of a laboratory setting.

If successful, the work could provide a standardized, scalable contrast agent for photoacoustic imaging and expand its use across biomedical research.

Photoacoustic imaging combines light and ultrasound to visualize biological tissues. While the technique can detect naturally occurring molecules such as hemoglobin, it lacks widely available contrast agents that can target specific tissues or disease sites. As a result, researchers often create their own materials, which vary from lab to lab.

Veneziano began working on the problem about eight years ago with collaborators at 911��. His team focused on developing a contrast agent using indocyanine green, an FDA-approved dye. Instead of relying on complex chemical processes, the group created a method based on self-assembly, allowing the dye molecules to form aggregates with controlled size and surface properties.

“We figured out a method to control the size of the assembly without the need for complex chemistry,” Veneziano said. “When you reduce the chemicals and the number of steps, you make it easier for manufacturing and future approval or at least to make something safer.”

The team refined the process to the point where researchers in the lab can reliably produce aggregates with specific characteristics tailored for specific applications. Early funding, including a previous VIPC Tier 1 award and a university seed grant, supported initial development and validation. The group published its findings in 2023 and began building collaborations with other researchers.

A key step in the work involved combining standard indocyanine green dye molecules with modified versions of this dye that allow for additional functionality, such as targeting specific cells or adding other fluorescent molecules. That approach helped turn the material into a more flexible platform that can be adapted for different research needs.

The current grant focuses on what Veneziano described as the transition from a “lab product” to something that could be used more broadly. That includes demonstrating reproducibility across batches, establishing quality control standards, and determining how long the material can be stored without losing effectiveness.

“When you want to commercialize a product, you need to demonstrate reproducibility and quality control,” he said. “From one batch to another batch, you always want the same properties.”

Veneziano and his collaborators are also working with 911��’s Office of Technology Transfer and filed a patent application related to the technology. The team founded a start-up, NanOptical Biomedical Inc., to pursue commercialization, and the team plans to seek additional funding through the Small Business Innovation Research and Small Business Technology Transfer programs.

At the same time, the research continues to evolve. The team is working with collaborators to adapt the platform for different applications, including adding fluorescent capabilities and improving targeting for specific diseases. “We are at a stage where we are learning from them, from their experience, from what they need, how to make our particle better,” Veneziano said.

Topics

Bioengineering

Bioengineering Primary Faculty

imaging

Virginia Innovation Partnership Corporation

Research

patent

Tech Transfer

911�� delivers first commercialization under Virginia’s Lab-to-Launch initiative

Katarina Benson — Wed, 25 Feb 2026 19:27:52 +0000

911�� delivers first commercialization under Virginia’s Lab-to-Launch initiative Katarina Benson Wed, 02/25/2026 - 14:27

911�� has become Virginia’s first R1 research institution to commercialize a product under the state’s new Lab-to-Launch initiative, marking an early milestone in the commonwealth’s push to accelerate university research into the market.

Anthony Fung. Photo provided

In January, the 911�� Research Foundation entered into a license agreement with serial entrepreneur Anthony Fung and his company Valorlox LLC for the patented technology GMU Dynamic Low Visibility Pneumatic Cofferdam, a coastal resilience system designed to protect against flooding. This is the first commercial product to move forward under the new statewide commercialization framework.

Invented at 911�� by the late George L. Donohue, professor emeritus and founding director of the Center for Air Transportation Systems Research at the College of Engineering and Computing, the cofferdam is an inflatable, permanently anchored system that when deployed creates a water-tight barrier in under 16 minutes without heavy equipment to protect vulnerable communities from most flood events. When not deployed, the system functions as a low-profile boardwalk, blending into waterfront environments rather than standing as a permanent wall.

The cofferdam’s potential to protect communities from floods while supporting economic growth is what attracted Fung, the Valorlox LLC founder and the commonwealth’s former deputy secretary of technology.

His support—as well as that of the Virginia Innovation Partnership Corporation (VIPC) and Mason Enterprise—has helped move the project toward commercialization. Valorlox is the first company in Virginia to complete a Virginia Fast-Track License, which enables them to apply for up to $50,000 in VIPC commercialization funding.

“The cofferdam project brings together everything I’ve learned about business, government, innovation, and solving real problems,” said Fung. “It’s exactly the kind of challenge I want to tackle.”

The cofferdam’s commercialization demonstrates how the Lab-to-Launch initiative is intended to work: university research, streamlined licensing, and experienced entrepreneurs working together to move innovation into the marketplace. The team is currently working on a prototype.

George L. Donohue. Photo provided

Developed through a collaboration between VIPC and the state’s six R1 research university partners—911��, Old Dominion University, University of Virginia, Virginia Commonwealth University, Virginia Tech, and William & Mary—the Lab-to-Launch initiative aims to significantly increase the number of startups emerging from Virginia’s universities and help move technological breakthroughs to the marketplace, through a “fast track license.” Instead of taking months, a licensing agreement can now take weeks.

“It’s been a strategy for the last five years,” said Paula Sorrell, 911��’s associate vice president for innovation and economic development. “911�� has created several programs to support the lab-to-market activities by providing wrap-around services for faculty. This not only helped build the pipeline of technologies ready for market and created the support system to make them successful, but then got this first technology through this terrific new state program.”

Designed for both commercial and residential use, the cofferdam system has potential applications for protecting homes, apartments, airports, military bases, hospitals, data centers, power generation facilities, tunnels, bridges, and rail systems.

“The potential for property damage avoidance in the future is hard to estimate, but could be huge,” Donohue said in an interview in 2026.

The invention has been years in development and Donohue shares the patents with former students, now 911�� alumni Adel Youssef, BS Systems Engineering ’20; Lucciana Remy, BS Systems Engineering ’20; Faris Masri, BS Systems Engineering ’20; and Murat Gokturk, BS Systems Engineering ’20.

The 911�� Research Foundation is a nonprofit organization dedicated to promoting and aiding research and scientific investigation at 911��. GMRF manages patents and commercializes intellectual property by negotiating licensing agreements with motivated entrepreneurs and members of the business community. 911�� has a number of technologies moving toward commercialization through the Lab-to-Launch initiative.

Mason Enterprise^TM is the host to federal, state, and local programs that support a portfolio of more than 33,000 start-ups and small businesses across Virginia. Last year participating companies received more than $2.8 billion in follow-on funding, and more than 58,000 entrepreneurs, small business owners, students, and research faculty attended workshops and educational programs, received individual counseling, were assisted with product development, resided in an incubator, or received intellectual property advice.

The commercialization of the cofferdam technology also supports Building a Climate-Resilient Society, one of the six interconnected solutions of 911��’s Grand Challenge Initiative, a comprehensive research framework to secure the future we want. Learn more.

Learn more about Mason Enterprise

IST professors unveil human-AI collaboration tool to automate cartoon colorization

tdonnel — Fri, 10 Oct 2025 18:37:16 +0000

IST professors unveil human-AI collaboration tool to automate cartoon colorization tdonnel Fri, 10/10/2025 - 14:37

In This Story

Sungsoo Ray Hong

Yotam Gingold

911�� Information and Sciences (IST) Assistant Professor Sungsoo Ray Hong has always loved cartoons. Now he’s helping the artists who make them.

Drawing on his expertise in human-computer interaction (HCI) and artificial intelligence (AI), Hong and colleague Yotam Gingold, an associate professor in the Department of Computer Science (CS) created ShadowMagic, a new human-AI collaboration tool designed to make one of the most time-consuming parts of comic creation faster and easier.

The idea for ShadowMagic emerged from interviews with professional cartoonists. Hong, Gingold and their PhD students wanted to reduce the burden of shadowing, a task many artists find repetitive and time-consuming.

“Professional cartoonists are sometimes producing content every other day,” said Hong, who is also director of 911��’s Alignment Lab. “You cannot commit to these kinds of deadlines doing everything by yourself. That's why the colorization industry is so helpful to professional cartoonists.”

Colorization is a multi-step process of line drawing, flatting, base colorization, adding shadows and lighting, backgrounds, and other special effects. It is “fairly standardized, especially in South Korea and growing throughout the United States,” said Hong, who is from South Korea. ShadowMagic builds on an earlier project, FlatMagic, another AI-driven colorization tool designed to support digital comic professionals.

While there are existing AI tools that help with colorization, Hong and Gingold found that these tools require more work than doing it manually. They wanted to design a system that better augments cartoonists’ work and cuts down on shadowing, a labor intensive and, according to cartoonists, decidedly uncreative part of the process.

“We looked at artistic challenges, usually tedious things that aren’t so fun for the artists and break down those problems, so that they can focus more on the creative parts of it,” said Gingold, who directs 911��’s Computational Reality, Creativity, and Graphics Lab.

Gringold explained that there are millions of pixels in an image, and if an artist wants to move or change the color of an object, they currently have to point at one pixel among the millions.

Yotam Gingold (left) and Ray Hong in Research Hall, presenting their colorization tool. Photo by Cristian Torres/Office of University Branding.

Gingold’s research applies computer science to visual, geometric, and design problems. He has “always been interested in sketching and how computers can help us express ourselves.” Many of his algorithms automate filling in pixels and handling visual constraints.

“The computers will do the math where we can write formulas to update all the other millions of pixels. Another example would be keeping lines parallel and corners perpendicular, and that’s where a lot of my research comes in,” he said.

Chuan Yan, PhD ’24, was recruited by Gingold for this project and conducted research on sketching and painting. Yan, now a postdoctoral research at Stanford University, brought expertise in computer graphics and sketch-related computer vision techniques, which he had studied extensively with Gingold.

The team built ShadowMagic as an Adobe Photoshop plug-in, and since its release, it has attracted a lot of interest from professional artists.

“Artists have expressed a strong desire for a tool that could free them from the labor-intensive flatting process,” said Yan. “This response is both exciting and humbling. It confirms that our research is addressing a real need in the industry yet also highlights the remaining challenges in making [the tool] ready for widespread adoption.”

Yan believes ShadowMagic is just the beginning of a broader shift in creative industries towards tools that amplify creativity rather than replace it.

“I am excited to witness and contribute to this transformation, helping to shape a future where AI acts as a powerful tool that amplifies human creativity rather than replacing it,” he said.

Read the full paper: ShadowMagic: Designing Human-AI Collaborative Support for Comic Professionals’ Shadowing by Amrita Ganguly, Chuan Yan, John Joon Young Chung, Tong Steven Sun, Yoon Kiheon, Yotam Gingold, and Sungsoo Ray Hong. It was presented at UIST 2024.

Topics

College of Engineering and Computing

comics

Tech Transfer

Artificial Intelligence

Mason Enterprise at 911�� propels entrepreneurship across the region

ckearney — Tue, 23 Sep 2025 20:18:05 +0000

Mason Enterprise at 911�� propels entrepreneurship across the region ckearney Tue, 09/23/2025 - 16:18

Northern Virginia and the Greater Washington Region is rapidly becoming one of the nation’s fastest-growing entrepreneurial destinations for investors and inventors, with 911��’s investments and partnerships as a key driver.

From Accelerate investor Conference 2024. Photo provided

The state’s largest university-based business incubator, Mason Enterprise partners with the university’s schools and institutes, big business, start-ups, and venture capital investors to advance a thriving ecosystem of entrepreneurship and economic growth. This contributed to making Virginia a top state for business, according to CNBC.

“911�� is powering Virginia’s future,” said 911�� President Gregory Washington. “The university is preparing students for high-demand careers, supporting entrepreneurs at every stage, and driving the growth of small businesses across the state. We’re not just in the degree business, we’re in the success business.”

Mason Enterprise played a key role in Virginia’s new Lab-to-Launch initiative, the first of its kind in the nation. Developed through a statewide collaboration led by 911�� and University of Virginia, with the Virginia Innovation Partnership Corporation (VIPC) and the state’s four other R1 research universities—Old Dominion University, Virginia Commonwealth University, Virginia Tech, and William & Mary—the initiative is designed to double the number of start-ups that originate from Virginia’s research universities and accelerate the commercialization of breakthrough technologies.

Mason Enterprise leadership and impact highlights include:

$2.8 billion in bank loans, lines of credit, venture capital, angel investment, new revenues, and government contracts secured in 2024
65 invention disclosures by faculty last year—a 150% increase over five years
Growth from 300 to 2,000 supported tech start-ups in five years
One in six of the businesses served by Mason Enterprise are veteran-owned
58,000 entrepreneurs, small business owners, students and faculty participated in 2,600 workshops in 2024 (up from 19,000 attendees in 2020)
Helped in the formation of 409 new companies in 2024
Helped in the creation and retention of 6,351 jobs in 2024

“We’re proud to be building a culture of innovation that is reaping benefits for the region and beyond,” said Paula Sorrell, 911��’s associate vice president of innovation and economic development. “The blend of education, research, and public–private partnerships has created a steady pipeline of new ideas and investments that ensure our regional and national competitiveness.”

The Mason Enterprise team, led by Sorrell, was recently recognized by the Virginia Association of Counties for its Accelerate Breakfast Series, which connects entrepreneurs and investors through curated pitch opportunities that strengthen the local start-up ecosystem and attract regional investment. In addition, the International Economic Development Council recognized Mason Enterprise for its multiyear efforts advancing the region’s tech innovation economy with its Innovation Ecosystem Building award, the result of creating several high-impact, tech start-up focused programs to help diversify the regional economy.

Mason Enterprise provides small business and start-ups with affordable office space, legal and accounting assistance, free mentoring, access to investor networks, makers’ spaces, and tailored programs designed to help get ideas get off the ground or take the next step to get to market. Working closely with VIPC and nearby local officials in Prince William, Arlington, and Fairfax counties, the team also manages the Small Business Administration’s (SBA) network, called the Virginia Small Business Development Center and the Department of War’s (DOW) Virginia APEX Accelerator.

Mason Enterprise will host its fifth annual Accelerate Investor Conference 2025 on November 5-6 at the new Fuse at Mason Square in Arlington, Virginia. This year’s venture capital event will feature keynote speaker Sid Banerjee, chief strategy officer for Medallia, as well as a fireside chat co-hosted by Virginia BIO CEO John Newby and Jeff Conroy, managing director of Bayeux Ventures and former CEO of Embody, a successful Virginia start-up.

In This Story

Paula Sorrell

Learn more about Mason Enterprise

Topics

Small Business Development Center

Youngkin launches university commercialization initiative to fast-track startups and accelerate innovation

ckearney — Wed, 13 Aug 2025 16:56:06 +0000

Youngkin launches university commercialization initiative to fast-track startups and accelerate innovation ckearney Wed, 08/13/2025 - 12:56

Virginia Governor Glenn Youngkin has launched a new Lab-to-Launch initiative to unlock innovation in Virginia by accelerating university research commercialization and technology transfer.

Developed through a bold statewide collaboration between Virginia Innovation Partnership Corporation (VIPC) and Virginia’s six R1 research university partners—911��, Old Dominion University, the University of Virginia, Virginia Commonwealth University, Virginia Tech, William & Mary—this initiative aims to double the number of startups that spin out annually from Virginia’s research universities and propel technology breakthroughs into the marketplace.

Governor Youngkin joined by Secretary of Commerce and Trade Juan Pablo Segura, VIPC President and CEO Joe Benevento, Secretary of Education Aimee Guidera, representatives of Virginia’s research universities, including 911��'s Paula Sorrell, and business leaders at ceremonial MOU signing. Photo by Kaitlyn DeHarde/Governor's Office

The Lab-to-Launch initiative will create Virginia’s first-ever standardized Fast-Track License agreement to commercialize university research, while also expanding opportunities to connect with talent and capital from the private sector.

“Virginia is home to world-class research university institutions, and with Lab-to-Launch and the Virginia Fast-Track License, we are moving at the speed of business to accelerate commercialization pathways for university technology startups,” said Youngkin. “Since 2022, we’ve seen a record 15,000+ high-growth startups launch in Virginia, and we are now ranked top 10 in the nation for both technology and innovation and access to capital. Virginia is leading the way, and I look forward to seeing the transformative discoveries that go from ‘lab to launch’ and enhance people’s lives, not only in Virginia but throughout the country.”

Virginia Fast-Track License for Startups

Standardizes key terms in university intellectual property (IP) license agreements with startups and streamlines the university technology transfer process to make it easier, faster, less costly, and more transparent for scientists, inventors, and entrepreneurs.
Offers some of the most founder-friendly, standard university license economic terms in the country for entrepreneurs.
Startups that spin off from universities using the Virginia Fast-Track License are eligible for a grant award of up to $50,000 from VIPC toward upfront out-of-pocket university commercialization costs.

Private-Sector Collaboration with University Commercialization

Launch Entrepreneur-in-Residence program to connect industry experience and business acumen with technical knowledge and scientific expertise.
Create digital database and online catalog for university IP to make it easier for industry partners to access and engage with university innovation pipelines.
Attract private-sector investment for university startup spin-offs by engaging with venture capital funds and investor networks and evaluating potential partnership opportunities through VIPC’s Virginia Invest platform.

“Once again, Virginia is at the forefront because Virginia is open for business,” said Secretary of Commerce and Trade Juan Pablo Segura. “I cannot wait to see its impact from the extraordinary work, talent, and technology we have in our universities as we continue to unlock Virginia’s potential when it comes to innovation, technology, and everything it has to offer.”

“Virginia’s leading university hubs play an essential role in our innovation ecosystems and in catalyzing groundbreaking research discoveries,” said Joe Benevento, VIPC’s president and CEO. “Collaboration and innovation are at the heart of VIPC. This statewide partnership with Virginia’s R1 universities will elevate the commonwealth’s national leadership and launch a new frontier of innovation-driven growth and opportunity.”

As part of Lab-to-Launch, university partners will seek ways to identify and share best practices to grow research commercialization efforts in Virginia. VIPC will also measure and benchmark statewide university commercialization outcome metrics against historical baselines as well as national peers.

“Lab-to-Launch puts Virginia in a strong competitive position to connect business experience with faculty innovators, offer start-ups access to university technology with clear terms, and create a clear path to seed capital,” said Paula Sorrell, associate vice president of innovation and economic development at 911��. “It’s a win for tech start-ups, 911��, and the commonwealth.”

Achieve your entrepreneurial goals with Mason Enterprise

Topics

Innovation Awards recognize 911�� researchers

ckearney — Thu, 26 Jun 2025 15:00:11 +0000

Innovation Awards recognize 911�� researchers ckearney Thu, 06/26/2025 - 11:00

In May, 911�� celebrated its research enterprise with Innovation Awards. Hosted by the Office of Research, Innovation, and Economic Impact, the event recognized researchers, a start-up, and those who received and/or licensed a patent in the past two years.

From left, 911�� researchers Lance Sherry, Mikell Paige, and Craig Yu received Innovator Awards. Photo by Ayman Rashid/Office of University Branding

“We're deeply committed to fostering a research environment that encourages innovation and supports discovery,” said Provost James Antony in his opening remarks. “We want to ensure that the faculty have the tools, the partnerships, and the resources that they need to take their ideas further.”

Antony also commended the researchers for mentoring 911�� students. “You set a powerful example for emerging scholars. You show them what it's like to be both a researcher and a changemaker.”

At the event, the university awarded its second Mason Lifetime Disclosure Award, which recognizes a researcher with the most innovation disclosures. The first recipient was Lance Liotta, codirector and cofounder of the Center for Applied Proteomics and Molecular Medicine (CAPMM). It was Liotta who presented this year’s award to his CAPMM cofounder and codirector Emanuel Petricoin.

Petricoin, who joined 911�� in 2005, is a cofounder of four life science companies: Theranostics Health Inc., Ceres Nanosciences Inc., C-4 Diagnostics Inc., and Perthera Inc. He also is a coinventor on 40+ patents and has published more than 350 peer-reviewed publications.

CAPMM's Kelsey Mitchell with Paula Sorrell, associate vice president of innovation and economic development. Photo by Ayman Rashid/Office of University Branding

This year’s Mason Start-Up of the Year went to Mingkui Wei, an associate professor in the Department of Cyber Security Engineering, and his company CyberMirage. CyberMirage, which started as a collaborative research project involving researchers in network security with experts from both academia and industry, offers solutions to protect websites against web content theft and copyright infringement.

Three groups of researchers received 911�� Licensed Technology Awards, which celebrates when a protected intellectual property, such as a patent, is licensed by a company.

Kathryn Laskey of the College of Engineering and Computing (CEC) and Paul Houser of the Geography and Geoinformation Science Department in the College of Science had their prototype system licensed by Global MapAid, a nonprofit working in Africa. The technology maps groundwater to help small farmers locate better wells and create soil conservation programs.
Leading biotechnology tools provider Targeted Bioscience licensed a tissue collection method patented by the CAPMM team of Liotta, Alessandra Luchini, Marissa Howard, and biosciences PhD candidate Purva Gade.
Toronto-based Affinity Diagnostics licensed a method for sequestering and/or isolating analytes of interest from an oral fluid, also developed by a CAPMM team. Researchers Ahana Byne, Fatah Kashanchi, and Kelsey Mitchell joined Luchini, Liotta, and Howard on this award.

The Office of Research, Innovation, and Economic Impact also gave out Innovator Awards in the categories of sustainability, biohealth innovation, and digital innovation.

CEC’s Lance Sherry was recognized with the Innovators Award in Sustainability for his work with contrail mitigation. His pioneering research and technologies have not only enhanced flight safety and operational efficiencies but have also addressed aviation's growing efforts to track and mitigate the environmental impacts and to quantify their CO2 equivalency.

The College of Science’s Mikell Paige was recognized with the Innovators Award in Biohealth Innovation for his groundbreaking work in biochemistry at the interface of synthetic organic chemistry, drug discovery, and molecular design. His work focuses on designing small molecules that target computational modeling and biochemical assays to produce drug development in meaningful and practical ways.

Craig Yu of the College of Engineering and Computing received the Innovators Award in Digital Innovation for developing groundbreaking systems that redefine how people interact with virtual and augmented spaces. Through his research, Yu has developed a more human-centered approach to navigation, designing digital pathways that take into account physical effort and make virtual experiences more natural and inclusive.

“At 911��, we’re not just advancing research—we’re building a culture of innovation that has real-world impact,” said Andre Marshall, vice president for research, innovation, and economic impact. “These awards are about honoring the bold ideas and the committed people who move the university’s research forward—and outward—into the world. They represent the spirit of innovation that defines our university: impactful, collaborative, and driven by a desire to make a difference far beyond our campus.”

The awards the researchers took home for patents and licensed technologies have a special design. They are Plexiglas hexagons with magnets so researchers can add to their award over the years as they receive patents/licensing.

The researchers and teams behind 19 911�� patents were also recognized.

Compositions and methods for laser capture microdissection—Virginia Espina, Lance Liotta, and Alessandra Luchini
Collapsible fluid collection system for point-of-care diagnostics—Marissa Howard, Liotta, Luchini, and Kelsey Mitchell
Honey proteomics for honeybee disease and environmental biomonitoring—Liotta and Luchini
Antimicrobial peptides and related methods—Shravani Bobde
Molecularly imprinted particles—Barney Bishop, Mrinalini Ramanan, and Yaling Zhu
Systems and methods for coordinating travel through traffic lights—Melvin Friedman and Brian Mark
Impactor platform allowing freefall upon impact—David Cerri
Recombinant host cell with heterologous nucleic acids encoding SHREK proteins—Deemah Dabbagh and Yuntao Wu
Methods for breast cancer treatment—Emanuel Petricoin and Julia Wulfkuhle
Anti-fibrotic agent—Mikell Paige and Gregory Petruncio
Using Wi-Fi infrastructure to predict locations and contacts—Janusz Wojtusiak
Methods and systems for system call reduction—Kun Sun
Systems and methods for improved aircraft safety—Lance Sherry
Exertion-aware path generation—Lap-Fai (Craig) Yu
Complex user authentication factor integrating a sequence of fingerprints and a personal identification number—Massimiliano Albanese
Small molecule inhibitors of SLC25A1—Mikell Paige
Mining all atom simulations for diagnosing and treating disease—Mohsin Jafri
Antimicrobial peptides and related methods—Monique van Hoek
Look-up table containing processor-in-memory cluster for data-intensive applications—Sai Manoj and Sathwika Bavikadi

Research at 911��

Topics

Research

Tech Transfer

patent

Engineering professors develop human-AI colorization tool for cartoonists

sbrown79 — Mon, 03 Mar 2025 17:28:34 +0000

Engineering professors develop human-AI colorization tool for cartoonists sbrown79 Mon, 03/03/2025 - 12:28

911�� professor Sungsoo Ray Hong has always been a huge fan of cartoons, comics, and animations. By combining his passion with his research area of human-computer interaction, he has created a new tool for cartoonists, ShadowMagic.

Hong, his colleague Yotam Gingold, and their PhD students published a paper, “ShadowMagic: Designing Human-AI Collaborative Support for Comic Professionals’ Shadowing,” elucidating the need for the tool, which aims to boost product quality and designer productivity through study-informed human-AI interaction.

The team worked with professional cartoonists to find common workflow of colorization that is shared within the industry as a reference point for their research, which examines the evolution of designing technology as cartoonists transitioned from using PCs in the 1980s to artificial intelligence, said Hong, who is an assistant professor at the Department of Information Sciences and Technology.

Creating a comic book is a team effort as there are many roles throughout the process including story drafting, sketching, colorizing, editing, and sending to a production company, said Hong.

Colorization is a sequential process of line drawing, flatting, base colorization, shadows and/or lighting, background and other special effects. The tool stems from a previous project, FlatMagic, another AI-driven tool designed to improve the creative process for digital comic professionals.

“This is a fairly standardized process, especially in South Korea and growing throughout the United States as well,” he explained. “The solutions to these network visualizations should be contextualized, but we have the limited resources. We can’t build everything for everybody. That’s my motivation here.”

Gingold also specializes in human-computer interaction and “has always been interested in sketching and how computers can help us express ourselves,” said the Department of Computer Science associate professor.

Yotam Gingold (left) and Ray Hong in Research Hall, presenting their colorization tool. Photo by Cristian Torres/Office of University Branding.

“We looked at artistic challenges, usually tedious things that aren’t so fun for the artists and break down those problems, so that they can focus more on the creative parts of it,” said Gingold, who is the director of 911��’s Computational Reality, Creativity, and Graphics Lab.

There are millions of pixels in an image, and if an artist wants to move or change the color of a building for example, they point at one pixel among the millions. The artist wants the rest of the pixels to follow along naturally so the rest of the building should also change, he explained.

While a doctoral student at 911��, Chuan Yan, PhD ’24, was recruited by Gingold for this project and conducted research on sketching and painting. Yan’s area of expertise encompasses computer graphics fundamentals and sketch-related computer vision techniques, which he had learned extensively from Gingold, he explained.

The ShadowMagic tool was built as an Adobe Photoshop plug-in, and since its release, the team “has garnered significant interest from artists inquiring about updates and expressing a strong desire for a tool that could free them from the labor-intensive flatting process,” said Yan, who is currently a postdoc researcher at Stanford University.

“This response is both exciting and humbling. It confirms that our research is addressing a real need in the industry yet also highlights the remaining challenges in making [the tool] ready for widespread adoption.”

Yan believes that as more sophisticated generative AI systems continue to emerge, AI-human collaboration will become increasingly vital.

“I am excited to witness and contribute to this transformation, helping to shape a future where AI acts as a powerful tool that amplifies human creativity rather than replacing it,” he said.

Discover more Artificial Intelligence research from 911��

In This Story

Sungsoo Ray Hong

Yotam Gingold

Tech Transfer

Microgrids meet the market

Related Stories

In This Story

Topics

911�� licenses cancer imaging technology to biotech company

Related News

Topics

911�� and Phase Inc. receive NSF grant to advance 3D-printed microfluidic technology

Related Stories

In This Story

Topics

Imagining an imaging breakthrough

In This Story

Topics

911�� delivers first commercialization under Virginia’s Lab-to-Launch initiative

Related Stories

IST professors unveil human-AI collaboration tool to automate cartoon colorization

In This Story

Topics

Mason Enterprise at 911�� propels entrepreneurship across the region

In This Story

Related Stories

Topics

Youngkin launches university commercialization initiative to fast-track startups and accelerate innovation

Related News

Topics

Innovation Awards recognize 911�� researchers

Related Stories

Topics

Engineering professors develop human-AI colorization tool for cartoonists

In This Story

Related News

Tech Transfer

Microgrids meet the market

Related Stories

In This Story

Topics

911���� licenses cancer imaging technology to biotech company

Related News

Topics

911���� and Phase Inc. receive NSF grant to advance 3D-printed microfluidic technology

Related Stories

In This Story

Topics

Imagining an imaging breakthrough

In This Story

Topics

911���� delivers first commercialization under Virginia’s Lab-to-Launch initiative

Related Stories

IST professors unveil human-AI collaboration tool to automate cartoon colorization

In This Story

Topics

Mason Enterprise at 911���� propels entrepreneurship across the region

In This Story

Related Stories

Topics

Youngkin launches university commercialization initiative to fast-track startups and accelerate innovation

Related News

Topics

Innovation Awards recognize 911���� researchers

Related Stories

Topics

Engineering professors develop human-AI colorization tool for cartoonists

In This Story

Related News

911�� licenses cancer imaging technology to biotech company

911�� and Phase Inc. receive NSF grant to advance 3D-printed microfluidic technology

911�� delivers first commercialization under Virginia’s Lab-to-Launch initiative

Mason Enterprise at 911�� propels entrepreneurship across the region

Innovation Awards recognize 911�� researchers